‘Underwhelming’ Improvements in mCRC Overall Survival
Despite significant improvements in overall survival for patients with metastatic colorectal cancer (mCRC) over the past few decades, the advances have been incremental, with few large gains, according to a new systematic review. Researchers created two databases to compare statistical results from phase 3 trials of systemic mCRC therapies published between 1986 and 2016 with …
‘Underwhelming’ Improvements in mCRC Overall Survival Read More »









